Mortality in Low-mortality DRGs | Model 1 Hospital random effect | Model 2 adds age-sex fixed-effect | Model 3 adds comorbidity fixed-effect |
---|---|---|---|
Patient variables (OR 95% CI) | |||
Constant | 0.001 (0.0005 to 0.007) | ||
Measures of clustering | |||
Hospital level variance (SE) | 0.20 (0.07) | ||
Rho (95% CI) | 0.06 (0.03 to 0.11) | ||
MOR (95% CI) | 1.53 (1.35 to 1.81) | ||
Decubitus Ulcer | Model 1 Hospital random effect | Model 2 adds age-sex fixed-effect | Model 3 adds comorbidity fixed-effect |
Patient variables (OR 95% CI) | |||
Constant | 0.008 (0.007 to 0.009) | 0.00015 (0.00013 to 0.0002) | 0.00018 (0.00015 to 0.0002) |
Age | 1.053 (1.052 to 1.055) | 1.046 (1.045 to 1.047) | |
Sex | 1.11 (1.08 to 1.14) | 1.14 (1.09 to 1.17) | |
Paralysis | 5.05 (4.81 to 5.31) | ||
Other neurological disorders | 3.74 (3.59 to 3.89) | ||
Diabetes w chr. complications | 1.87 (1.79 to 1.99) | ||
Weight loss | 5.16 (4.85 to 5.47) | ||
Fluid And electrolyte disorders | 2.97 (2.83 to 3.13 | ||
Measures of clustering | |||
Hospital level variance (SE) | 0.54 (0.43 to 0.68) | 0.46 (0.37 to 0.58) | 0.38 (0.29 to 0.47) |
Rho (95% CI) | 0.14 (0.12 to 0.17) | 0.12 (0.10 to 0.15) | 0.10 (0.08 to 0.13) |
MOR (95% CI) | 2.01 (1.86 to 2.18) | 1.91 (1.78 to 2.06) | 1.79 (1.68 to 1.92) |
Catheter-related infection | Model 1 Hospital random effect | Model 2 adds age-sex fixed-effect | Model 3 adds comorbidity fixed-effect |
Patient variables (OR 95% CI) | |||
Constant | 0.001 (0.0009 to 0.0012) | 0.0012 (0.001 to 0.0014) | 0.0012 (0.001 to 0.0015) |
Age | 1.017 (1.016 to 1.018) | 1.014 (1.013 to 1.015) | |
Sex | 0.47 (0.44 to 0.49) | 0.49 (0.46 to 0.51) | |
Peripheral vascular disease | 2.05 (1.84 to 2.29) | ||
Paralysis | 2.20 (1.93 to 2.56) | ||
Weight loss | 3.63 (3.03 to 4.35) | ||
Fluid And electrolyte disorders | 2.36 (2.09 to 2.66) | ||
Measures of clustering | |||
Hospital level variance (SE) | 1.10 (0.84 to 1.44) | 1.11 (0.85 to 1.45) | 1.05 (0.80 to 1.38) |
Rho (95% CI) | 0.25 (0.20 to 0.31) | 0.25 (0.20 to 0.31) | 0.24 (0.20 to 0.30) |
MOR (95% CI) | 2.71 (2.39 to 3.13) | 2.72 (2.39 to 3.14) | 2.65 (2.38 to 3.06) |
Postoperative PE or DVT | Model 1 Hospital random effect | Model 2 adds age-sex fixed-effect | Model 3 adds comorbidity fixed-effect |
Patient variables (OR 95% CI) | |||
Constant | 0.0046 (0.0043 to 0.005) | 0.00065 (0.00055 to 0.0007) | 0.00059 (0.00052 to 0.0007) |
Age | 1.031 (1.029 to 1.032) | 1.029 (1.028 to 1.03) | |
Sex | 0.96 (0.92 to 1.002) | 1.02 (0.82 to 1.06) | |
Pulmonary circulation disease | 2.39 (2.16 to 2.66) | ||
Paralysis | 2.32 (2.07 to 2.58) | ||
Lymphoma | 2.14 (1.69 to 2.69) | ||
Metastatic cancer | 2.80 (2.56 to 3.03) | ||
Solid tumor w/o metastasis | 1.84 (1.65 to 2.03) | ||
Coagulopthy | 2.89 (2.56 to 3.25) | ||
Weight loss | 2.58 (2.25 to 2.94) | ||
Measures of clustering | |||
Hospital level variance (SE) | 0.26 (0.19 to 0.33) | 0.24 (0.19 to 0.31) | 0.20 (0.15 to 0.26) |
Rho (95% CI) | 0.07 (0.06 to 0.09) | 0.07 (0.05 to 0.09) | 0.06 (0.04 to 0.07) |
MOR (95% CI) | 1.62 (1.53 to 1.73) | 1.59 (1.51 to 1.70) | 1.53 (1.45 to 1.63) |
Postoperative sepsis | Model 1 Hospital random effect | Model 2 adds age-sex fixed-effect | Model 3 adds comorbidity fixed effect |
Patient variables (OR 95% CI) | |||
Constant | 0.014 (0.013 to 0.015) | 0.006 (0.005 to 0.007) | 0.0068 (0.0059 to 0.0077) |
Age | 1.022 (1.021 to 1.023) | 1.019 (1.018 to 1.02) | |
Sex | 0.63 (0.61 to 0.66) | 0.64 (0.61 to 0.66) | |
Congestive heart failure | 2.51 (2.36 to 2.69) | ||
Paralysis | 2.16 (1.95 to 2.39) | ||
Weight loss | 3.39 (2.91 to 3.89) | ||
Measures of clustering | |||
Hospital level variance (SE) | 0.28 (0.21 to 0.37) | 0.31 (0.24 to 0.41) | 0.30 (0.23 to 0.39) |
Rho (95% CI) | 0.08 (0.06 to 0.10) | 0.09 (0.07 to 0.11) | 0.08 (0.07 to 0.11) |
MOR (95% CI) | 1.65 (1.55 to 1.78) | 1.70 (1.59 to 1.84) | 1.69 (1.58 to 1.82) |